Background & Aims: Protease-activated receptor 2 can be stimulated by interstitially released trypsin during acute inflammation of the pancreas. In this study, we investigated the roles of pancreatic and circulatory protease-activated receptor 2 in the pathogenesis of acute pancreatitis by using in vitro and in vivo model systems. Methods: Physiological and pathologic effects of protease-activated receptor 2 activation were measured in isolated pancreatic cells and in rats with experimental pancreatitis. Consequences of protease-activated receptor 2 activation on the systemic and inflammatory responses were measured after treatments with trypsin or protease-activated receptor 2-activating peptide. Results: Stimulation of protease-activated receptor 2 in rat pancreatic acinar cells activated short-lasting (Ca 2؉ signaling) and long-lasting (extracellular signal-related kinase) signaling pathways and protected the cells against bile-induced cell damage. More importantly, protease-activated receptor 2 activation ameliorated the pathologic effects observed in the in vivo model of cerulein-induced pancreatitis. Trypsin in the circulation of rats with taurocholate-induced severe acute pancreatitis reached levels sufficient to activate endothelial and immune cells to stimulate nitric oxide and interleukin-8 production, respectively. Most notably, activation of systemic protease-activated receptor 2 by circulating protease-activated receptor 2 agonists induced a hemodynamic response pattern similar to that observed in rats with severe acute pancreatitis. The effects of proteaseactivated receptor 2 agonists and acute pancreatitis were not additive. Conclusions: These findings suggest that protease-activated receptor 2 may have a dual role in acute pancreatitis: protecting acinar and duct cells against pancreatitis-induced cell damage while mediating or aggravating the systemic complications of acute pancreatitis, which are the major cause of mortality in the early phase of necrotizing pancreatitis.
A cute pancreatitis is a disease with increasing incidence that is associated with high morbidity and mortality. Approximately 25% of patients develop severe inflammation with pancreatic and peripancreatic necrosis that requires intensive care. 1 Despite recent progress in diagnostic tools and supportive care, the overall mortality from the severe form of the disease is still high. Death from severe acute pancreatitis can occur in an early or late stage of the disease. Early death occurs from systemic complications with multiple organ failure, whereas late death results from local pancreatic or intra-abdominal infection. 1, 2 The pathogenic mechanisms responsible for the early multiple organ failure remain poorly understood.
A defining feature of acute pancreatic inflammation is the release of digestive enzymes to the pancreatic interstitium and to the systemic circulation. 3, 4 Indeed, an increase of serum amylase is one of the indicative markers for the diagnosis of acute pancreatitis. Consequently, it was suggested that autodigestion of pancreatic tissue by activated proteolytic enzymes-particularly trypsin-is a leading cause of pancreatic necrosis. 5 This raises the possibility that protease-activated receptor (PAR) in the pancreas and cells of the circulatory system can be activated by interstitially released pancreatic enzymes and that activation of PAR mediates several of the side effects observed in acute pancreatitis.
PARs are a family of G protein-coupled receptors that are activated by proteolytic cleavage of their extracellular N-terminal domain by serine proteases and the resultant interaction of the newly formed N-terminal tethered ligand with the receptor. So far, 4 members of the PAR family have been identified. Activation of PAR1, PAR3, and PAR4 is relatively specific to thrombin, whereas PAR2 is activated by mast cell tryptase and pancreatic trypsin. 6 PAR2 is widely expressed in human and animal tissues, including the pancreas, lung, and immune and endothelial cells. [7] [8] [9] Recent studies have indicated that PAR2 can mediate various cellular responses, including smooth muscle contraction, 10, 11 relaxation, 10 and exacerbation of the inflammatory response. 12 It is important to note, however, that in general little is known about the physiological roles of PAR2, because active trypsin does not exist in most normal physiological situations, except for the intraluminal space of the small intestine. Even in inflammation, the role of PAR2 remains to be fully defined, because PAR2 can protect against or enhance the response, depending on the activated cell type. 6 For example, PAR2 activation induces neurogenic inflammation 13 and activates inflammatory cells, including neutrophils. 14 By contrast, PAR2 activation protects against airway and colonic inflammation. 15, 16 In this regard, acute pancreatitis is a unique situation in which a large amount of active trypsin can stimulate PAR2 in the systemic circulatory system, as well as locally in the pancreatic tissue.
In this study, we examined the role of PAR2 in acute pancreatitis by using molecular and functional approaches in in vitro and in vivo model systems. We found that activation of PAR2 exerts a protective effect on pancreatic acinar and duct cells during acute inflammation of the pancreas. Conversely, PAR2 stimulation activated immune and endothelial cells. Accordingly, PAR2 activation during acute pancreatitis resulted in a precipitous reduction in blood pressure and its consequent hemodynamic effects, which may aggravate the systemic complications of acute pancreatitis. These findings provide new insight into understanding the pathogenesis of acute pancreatitis and offer new modalities in developing PAR2-based treatments for acute pancreatitis.
Materials and Methods

Animals, Chemicals, and Solutions
Adult male Sprague-Dawley rats weighing 200 -300 g were used for animal experiments. All experiments with animals were performed under appropriate anesthesia, and this study was approved by the Committee on Animal Research at Yonsei Medical Center. PAR2-activating peptide (AP) (SLIGRL-NH 2 ) and PAR4-AP (AYPGKF-NH 2 ) were synthesized at the Korean Basic Science Institute (Seoul, Korea). The synthetic trypsin inhibitor camostat was a generous gift from Ono Pharmaceutical Co. (Osaka, Japan). Fura-2-AM, 2Ј,7Ј-bis(2-carboxyethyl)-5(6)-carboxyfluorescein (BCECF) acetoxymethyl ester, and 5-(and 6-) chloromethyl-2Ј,7Ј-dihydrodichlorofluorescein diacetate acetyl ester were purchased from Molecular Probes (Eugene, OR). All other chemicals, including trypsin and thrombin, were purchased from Sigma (St. Louis, MO).
The standard perfusate was termed solution A and contained (in mmol/L) 140 NaCl, 5 KCl, 1 MgCl 2 , 1 CaCl 2 , 10 Dglucose, and 10 HEPES (pH 7.4 with NaOH). The HCO 3 Ϫ -buffered, high-K ϩ (100 mmol/L K ϩ ) solution B contained (in mmol/L) 25 NaCl, 100 KCl, 1 MgCl 2 , 1 CaCl 2 , 10 D-glucose, 5 HEPES, and 25 NaHCO 3 (pH 7.4 with NaOH). The HCO 3 Ϫ -buffered, high-K ϩ (100 mmol/L K ϩ ), Cl Ϫ -free solution C contained (in mmol/L) 25 Na ϩ -gluconate, 100 K ϩ -gluconate, 1 MgSO 4 , 9.3 hemicalcium cyclamate, 10 D-glucose, 5 HEPES, and 25 NaHCO 3 (pH 7.4 with NaOH). All HCO 3 Ϫ -buffered solutions were continuously gassed with 95% oxygen and 5% CO 2 to maintain constant HCO 3 Ϫ and pH.
Isolation of Pancreatic Acini, Extracellular Signal-Related Kinase Phosphorylation, and Cell-Survival Analysis
Rat pancreatic acini were isolated as reported previously, 17 except for the use of collagenase CLS4 (Worthington, Lakewood, NJ) at 4 mg/15 mL. Aseptically isolated pancreatic acinar cells were cultured in Waymouth's MB751/1 medium containing 10% fetal bovine serum, penicillin 100 U/mL, and streptomycin 100 g/mL. For measurement of extracellular signal-related kinase (ERK) phosphorylation, acinar cells were incubated in warm (37°C) Waymouth media for 6 hours before PAR2 stimulation to reduce the background ERK activity, which would be induced by the stresses imposed by cell isolation. Immunoblotting of protein samples from acinar cells was performed as described below by using anti-phospho-ERK antibodies (New England Biolabs, Beverly, MA). For cell-survival analysis, after the 6-hour stabilization, acini were incubated with the desired concentration of PAR2-AP for 15 hours, and the cell-survival rate was measured with a 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide-based method (Boehringer Mannheim, Mannheim, Germany), as reported previously. 18 
Cell Cultures
CAPAN-1 cells (human pancreatic ductal adenocarcinoma) were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum and plated on permeable supports fabricated from Transwell-Clear Polyester membrane (0.4-m pore diameter; Costar, Cambridge, MA), as previously described. 19 Human THP-1 myelomonocytoma cells were grown in RPMI 1640 with L-glutamine 2 mmol/L and 10% fetal bovine serum. Human umbilical vein endothelial cells (HUVEC) cells were grown in endothelial cell basal medium-2 supplemented with EGM-2 MV (Clonetics, San Diego, CA) and 2% fetal bovine serum.
Reverse-Transcription Polymerase Chain Reaction and Immunoblotting
The messenger RNA (mRNA) transcripts of PAR isoforms and interleukin (IL)-8 were analyzed by reversetranscription polymerase chain reaction (RT-PCR) in rat pancreatic tissues, isolated acinar cells, and THP-1 cells. Total RNA was extracted by using a Trizol solution (Invitrogen, Carlsbad, CA) and was reverse-transcribed by using random hexamer primers and a ribonuclease H Ϫ reverse transcriptase (Invitrogen). The complementary DNA was amplified with specific primers and a Taq polymerase (Promega, Madison, WI). The primer sequences used were as follows: rPAR1-sense, 5Ј-TTC CCG CGT TCC TAT GAG ACA G-3Ј; antisense, 5Ј-TCC GAA AGA CAA ACA CAG CGA TG-3Ј; size of PCR product, 350 base pairs (bp); rPAR2-sense, 5Ј-GCA CCG GGA CCC AAC AGT AAA G-3Ј, antisense, 5Ј-TGG AGG TGG TAG GAG ATC TTC AGG-3Ј; size of PCR product, 329 bp; rPAR3-sense, 5Ј-CTG CAC ACT TAG TGA CAT CCC ATA AC-3Ј, antisense, 5Ј-TCA CGA TGT TCG CTG GTA CAC C-3Ј; size of PCR product, 376 bp; rPAR4 -sense, 5Ј-GAG TAC CAG GGA AGG CCA AGA AG-3Ј; antisense, 5Ј-GCT GGC CAC GCA GGT GAT AAA C-3Ј; size of PCR product, 364 bp; h␤-actin-sense, 5Ј-TGT GAT GGT GGG AAT GGG TCA G-3Ј; antisense, 5Ј-TTT GAT GTC ACG CAC GAT TTC C-3Ј; size of PCR product, 511 bp; hIL-8 -sense, 5Ј-ATG ACT TCC AAG CTG GCC GTG GCT-3Ј; antisense, 5Ј-TCT CAG CCC TCT TCA AAA ACT TCT C-3Ј; size of PCR product, 297 bp.
For immunoblotting, the proteins were extracted from acinar and CAPAN-1 cells by using a lysis buffer containing 20 mmol/L Tris (pH 7.8 with HCl), 150 mmol/L NaCl, 2 mmol/L ethylenediaminetetraacetic acid (pH 8.0), 1% Triton X-100, 0.1 mol/L dithiothreitol, 40 g/mL phenylmethylsulfonyl fluoride, 4 g/mL aprotinin, and 1 g/mL leupeptin, and then 100 g of protein was separated by a sodium dodecyl sulfate-polyacrylamide gel. The separated proteins were transferred to nitrocellulose membranes and incubated with the respective primary and secondary antibodies. The immunoblots were developed with an enhanced chemiluminescence kit (Amersham Pharmacia, Piscataway, NJ). PAR isoform-specific antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA).
Measurements of Free Cytosolic Ca 2؉ Concentration and Intracellular pH
The free cytosolic Ca 2ϩ concentration ([Ca 2ϩ ] i ) was measured in pancreatic acini by using Fura-2 as previously described. 18 Briefly, Fura-2-loaded acini were plated on glass coverslips that formed the bottom of a perfusion chamber. 
Induction of Cerulein-Induced Pancreatitis and Morphological Studies
To assess the local protective effect of PAR2 stimulation, a mild form of intrapancreatic injury was induced by a single intraperitoneal injection of cerulein 40 g/kg. Rats were divided into 4 groups. Two hours after cerulein injection, rat pancreata were removed, and after trimming of fat tissue and lymph nodes, the wet weight of the pancreas was measured. Electron microscopy 18 and light microscopy with H&E staining 20 were performed as previously detailed. For electron microscopy, a small part of the head portion of the pancreas was fixed in an aldehyde solution containing 2% glutaraldehyde, 2% paraformaldehyde, 0.5% CaCl 2 , and 0.1 mol/L cacodylate (pH 7.4). The remaining part of the pancreas was fixed in 10% formaldehyde and used for light microscopic examinations. Electron microscopy images were collected with a transmission electron microscope (CM-10; Philips, Einthoven, the Netherlands). Morphometric analysis of light microscopic images was performed to evaluate the effects of PAR2 on tissue damage. Randomly selected areas of 360 ϫ 270 m were acquired digitally (BX50 microscope, Olympus, Tokyo, Japan; and Spot RT camera, Diagnostic Instruments Inc., Sterling Heights, MI), and the number of cells with apoptotic/necrotic debris and the total number of nuclei were counted by a pathologist who was unaware of the experimental protocols.
Electrophoretic Mobility Shift Assay and Determination of Interleukin-8 Release
The DNA-binding activity of nuclear factor-B (NF-B) was measured by an electrophoretic mobility shift assay, as described previously. 18 Briefly, the nuclear fraction of PAR2-AP-stimulated cells was isolated and incubated with a 32 Plabeled oligonucleotide corresponding to an NF-B binding sequence (5Ј-AGT TGA GGG GAC TTT CCC AGG C-3Ј). The samples were electrophoresed on a nondenaturing polyacrylamide gel (4%), and the dried gel was exposed to Kodak XR5 film (Rochester, NY) on an intensifying screen for 24 hours at Ϫ70°C.
For determination of IL-8 release, THP-1 cells were incubated with desired concentrations of PAR2-AP or tumor necrosis factor-␣ for 12 hours, and the supernatants were collected. The IL-8 level in the medium was determined by an enzyme-linked immunosorbent assay kit (R&D Systems, Minneapolis, MN).
Measurement of Nitric Oxide and Peroxynitrite
HUVEC cells grown on glass coverslips were loaded with the fluorescent marker 5-chloromethyl-2Ј,7Ј-dihydrodichlorofluorescein diacetate acetyl ester (10 mol/L), a cellpermeable and retainable derivative of 2Ј,7Ј-dihydrodichlorofluorescein (H 2 DCF), for 30 minutes and mounted in a perfusion chamber. H 2 DCF fluorescence was recorded at an excitation wavelength of 488 nm and an emission wavelength of 515 nm by using a Zeiss LSM510 confocal microscope (Jena, Germany). To minimize dye loss and photobleaching, PAR2-AP was added to the chamber by using a micropipette while halting perfusion and using the lowest possible laser intensity.
Induction of Taurocholate Pancreatitis and Trypsin Assay
A severe form of experimental pancreatitis was induced in Sprague-Dawley rats by retrograde infusion of sodium taurocholate into the pancreatic duct by using the protocol described previously. 20 Serum trypsin activity was measured by a fluorometric assay, which is based on the release of ␤-naphthylamide from the trypsin substrate ␣-N-benzoyl-DLarginine-␤-naphthylamide HCl (BzArgNap), as reported previously, 21 with minor modifications. Serum was collected from the portal vein 6 hours after the induction of pancreatitis. A total of 150 L of serum and 100 L (32 g) of BzArgNap were added to 2.75 mL of 0.1 mol/L Tris-HCl buffer (pH 8.0) and incubated for 1 hour at 40°C. Five micrograms of soybean trypsin inhibitor was then added to each tube to terminate the reaction, and the tubes were placed on ice for 10 minutes. The chilled reaction products were filtered through a short column containing 0.5 mL of Sephadex G-10 (Amersham Biosciences, Uppsala, Sweden), and the columns were washed with 0.5 mL of 0.1 mol/L Tris-HCl buffer (pH 8.0). The combined filtrates were warmed to 40°C to redissolve traces of crystalline BzArgNap before fluorometric analysis. The fluorescence was recorded at an excitation wavelength of 335 nm and an emission wavelength of 410 nm by using an SPF-500C spectrofluorometer (SLM Instruments, Inc., Rochester, NY). The fluorescence of each sample was calculated by subtracting the background fluorescence, which was obtained in the same procedure but without BzArgNap. By using the conditions described previously, linear dependence was obtained in trypsin concentrations between 0 and 8 g/mL.
Measurement of Arterial Blood Pressure
Control adult rats and rats with bile-induced acute pancreatitis were anesthetized with urethane (1.25 g/kg subcutaneously), and the left common carotid artery and jugular vein were cannulated. Arterial blood pressure and heart rate were recorded on a polygraph recorder (MK-III-S; Narco BioSystems, Austin, TX) while PAR2-AP or trypsin was infused through the jugular vein.
Statistical Analysis
The results of multiple experiments are presented as means Ϯ SEM, and statistical analysis was performed with analysis of variance or Student t tests, as appropriate. All P values were based on 2-sided comparisons, and P values Ͻ0.05 were considered to indicate statistical significance.
Results
Expression of Protease-Activated Receptor 2 in Pancreas
As a first step in studying the role of PAR in the pancreas, we analyzed the expression of the receptors by RT-PCR and immunoblotting. Expression of PAR2 in the pancreas has been reported previously. 7, 22 We extended these findings to show the expression of the receptors in isolated rat pancreatic acinar cells and to further show the expression of PAR2 in CAPAN-1 cells of a human pancreatic ductal adenocarcinoma origin ( Figure 1 ). RT-PCR analysis suggested high levels of PAR2 mRNA in rat pancreatic acini, a finding in accord with the high level of PAR2 protein observed by immunoblotting. Similarly, PAR2 protein was expressed at high levels in CAPAN-1 cells ( Figure 1B ). Low levels of PAR1, PAR3, and PAR4 mRNA and of PAR1 proteins were also detected in pancreatic acini. However, mRNAs for PAR3 and PAR4 were probably contamination derived from other cell types because a much stronger RT-PCR signal for these receptors was observed with RNA prepared from the whole pancreas (not shown).
Protease-Activated Receptor 2 in Pancreatic Acinar Cells
Because PAR2 is a Gq-coupled receptor, 6 we measured the effect of PAR2 activation on the [Ca 2ϩ ] i of freshly isolated pancreatic acinar cells. To avoid PAR2 desensitization before the first stimulation, the acinar cells were incubated in the primary culture media for 2 hours before [Ca 2ϩ ] i measurement. As shown in Figure  2A , trypsin 100 nmol/L, but not thrombin, evoked a transient [Ca 2ϩ ] i increase in pancreatic acini. Although PAR2 is preferably activated by trypsin, high concentrations of trypsin can also activate PAR4. 8 However, a PAR4-AP had no effect, whereas PAR2-AP increased [Ca 2ϩ ] i in the same pancreatic acini ( Figure 2B ). This is in agreement with the molecular data in Figure 1 . It is, therefore, clear that PAR2 is the predominantly functional PAR in pancreatic acinar cells. The [Ca 2ϩ ] i response evoked by PAR2 in acinar cells was rapidly desensitized, as is evident from the failure of repeated stimulation with trypsin or PAR2-AP to trigger a second [Ca 2ϩ ] i increase ( Figure 2C and D) . Prestimulation with trypsin 100 nmol/L, PAR2-AP 100 mol/L, and PAR2-AP 500 mol/L decreased the [Ca 2ϩ ] i increase mediated by trypsin 100 nmol/L by 91% Ϯ 4%, 48% Ϯ 7%, and 83% Ϯ 6%, respectively. This led to a minimal activation of Ca 2ϩ influx by PAR2 and, thus, to a minimal sustained increase in [Ca 2ϩ ] i .
As will be shown below, PAR2 has a long-lasting effect on pancreatic acinar cell function, yet the Ca 2ϩ signal is short. Therefore, we measured the activity of other signaling pathways to determine the duration of the PAR2 signals. Ca 2ϩ -mobilizing agonists, such as cholecystokinin, regulate the mitogen-activated protein kinase (MAPK) signaling pathway as well as upstream components of the MAPK cascade. 23 Although the role of MAPK activation in pancreatic inflammation is poorly understood, the pathway seems to be activated in response to various forms of cell stress and may thus play a role in cell survival. 24 Therefore, we examined whether the activation of PAR2 activates the MAPK pathway by measuring the phosphorylation of ERK, and whether the stimulated state can persist for a long time. As shown in Figure 2E , stimulation of pancreatic acinar cells with PAR2-AP increased the phosphorylation of ERK in a dose-dependent manner. The median effective dose for ERK phosphorylation was 7.4 Ϯ 3.7 mol/L, as estimated from the extent of p44 phosphorylation. It is important to note that ERK phosphorylation could be readily detected 15 minutes after cell stimulation with PAR2-AP (100 mol/L) and was as intense even after 2 hours.
In Vitro Protective Effects of ProteaseActivated Receptor 2 on Pancreatic Cells
The increase in [Ca 2ϩ ] i and activation of cell stress signals (Figure 2 ) raised the possibility that activation of PAR2 may affect acinar cell survival or death, at least acutely. To examine this possibility, we first measured the effect of PAR2 on the survival of pancreatic acinar cells in short-term culture by using the 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. As depicted in Figure 3A , there were no measurable changes in the viability of cells treated for 15 hours with PAR2-AP up to 500 mol/L. Hence, it is important to note that unlike the cell injury caused by the activation of pancreatic acini with supramaximal concentrations of Ca 2ϩ -mobilizing secretogogues, which depends on Ca 2ϩ influx and a sustained Ca 2ϩ increase, 25 stimulation with a supramaximal concentration of PAR2-AP is not associated with cell toxicity.
In a second protocol, we evaluated the protective effects of PAR2 stimulation on pancreatic acinar cells from imposed cell damage. For this, we used the in vitro bile-induced cell injury model. We have shown previously that treatment of pancreatic acinar cells with a low concentration of bile acids compromised the Ca 2ϩ -signaling machinery to cause a sustained Ca 2ϩ influx that led to cell death. 18 Overnight treatment with 0.05% bile caused 29.1% Ϯ 5.2% cell death, and, of note, this value was decreased to 13.2% Ϯ 3.9% by co-treatment with PAR2-AP 100 mol/L (P Ͻ 0.05; Figure 3B ). In an additional control, we found that when the cells were incubated with a high concentration of bile acids (0.2%, at which cell death is induced by the nonspecific detergent effect of bile acids 18 ), PAR2 activation had no effect.
To further examine the potential protective role of PAR2, we tested its effect on a pancreatic duct cell line, because the pancreatic duct also expresses PAR2 26 and because PAR2 is up-regulated in acute pancreatic lesions in the rat. 27 Critical to ductal protection is the copious secretion of HCO 3 Ϫ , as is evident from the loss of pancreatic function in cystic fibrosis, in which HCO 3 Ϫ secretion is compromised or absent. 28, 29 The pancreatic juice contains a high concentration of HCO 3 Ϫ , and a significant portion of ductal HCO 3 Ϫ secretion is mediated by a Cl Ϫ /HCO 3 Ϫ exchange mechanism in the luminal membrane of pancreatic duct cells 29 -31 -probably a cystic fibrosis transmembrane conductance regulatoractivated member of the SLC26 transporters. 32 Indeed, we have recently shown that trypsin activates the luminal Cl Ϫ /HCO 3 Ϫ exchange activity in CAPAN-1 cells. 19 In this study, we further characterized the effects of PAR2 by using PAR2-AP and polarized CAPAN-1 cells grown on a permeable support ( Figure 3C ). To isolate the Cl Ϫ -dependent HCO 3 Ϫ transport, high extracellular K ϩ (100 mmol/L) was used to inhibit K ϩ /Cl Ϫ co-transport and electrogenic Cl Ϫ exit pathways by impairing the countercurrent movement of K ϩ . 19 The basolateral side was preincubated with Cl Ϫ -free solutions to isolate the luminal membrane-specific transport. The luminal side was then intermittently perfused with Cl Ϫ -free solutions. The rate of Cl Ϫ -dependent HCO 3 Ϫ transport was estimated from the initial rate of pH i increase as a result of extracellular Cl Ϫ removal. Treatment with PAR2-AP markedly increased the rate of luminal Cl Ϫ -dependent HCO 3 Ϫ transport in CAPAN-1 cells from 0.128 Ϯ 0.021 ⌬pH/min to 0.432 Ϯ 0.048 ⌬pH/min (P Ͻ 0.01).
Protective Effects of Protease-Activated Receptor 2 in Cerulein-Induced Pancreatitis
The in vitro experiments in Figure 3 suggest that PAR2 may ameliorate the pancreatic injury observed in pancreatitis. We examined this possibility by testing the effect of PAR2 in an in vivo model of acute pancreatitis induced by infusing the rats with a high concentration of the cholecystokinin analogue cerulein. A total of 24 rats were divided into 4 groups as listed in Figure 4A . The rats received either saline (controls) or PAR2-AP (2 mg/kg in saline intraperitoneally) 5 minutes before cerulein injection (40 g/kg in saline intraperitoneally).
The pancreata were collected at 2 hours after induction of pancreatitis and were weighed to assess the extent of edema. Subsequently, the tissue was processed for light and electron microscopic examinations. As shown in Figure 4B , the injection of cerulein resulted in edema, as was evident from the increased pancreatic wet weight from 0.58% Ϯ 0.02% to 1.10% Ϯ 0.09% (pancreas weight/body weight). Notably, pretreatment with PAR2-AP reduced the edema, resulting in a pancreatic wet weight of 0.75% Ϯ 0.05%, which consisted of a 67% Ϯ 11% reduction of the cerulein effect. Morphological examination provided further support for the protective effect of PAR2-AP treatment. As shown in Figure 4C and D, cerulein induced prominent pancreatic injuries, including interstitial edema, intracellular vacuole formation, and the appearance of cell debris (arrow heads). Pretreatment with PAR2-AP markedly suppressed all the morphological changes induced by cerulein. Morphometric analysis of light microscopic images showed that an average of 5.6% Ϯ 0.7% of the cells in the pancreas of the cerulein-treated group contained cell debris, a marker indicative of dead cells. This value was reduced to 2.2% Ϯ 0.2% (P Ͻ 0.01) by PAR2-AP pretreatment.
Serum Trypsin in Experimental Pancreatitis
Interstitially released trypsin can enter the systemic circulation. This led to the suggestion that increased circulating trypsin activity is related to the development of systemic complications in acute pancreatitis-particularly pancreatitis-associated lung injuries (PALI). 4 Hence, we hypothesized that activation of PAR2 in systemic inflammatory cells may lead to the pathogenesis of multiorgan failure, which is frequently observed in the early phase of severe acute pancreatitis. Imperative to this hypothesis is that the circulating trypsin in acute pancreatitis reaches levels that can activate PAR2 in systemic inflammatory cells.
To evaluate trypsin concentrations in the circulation, we first evaluated the most suitable procedure for our purpose. Over the years, several methods have been developed to detect trypsin activity in the circulation; these are based on direct enzymatic assays of trypsin activity or on indirect byproduct assays, such as the assays based on measurements of trypsinogen activating peptide (TAP). 4 The TAP assays are in wide use because they have excellent sensitivity and suffer less from intersample variations. However, we decided to use the BzArgNapbased enzymatic assay for several reasons: (1) the TAP concentration may not report the true trypsin concentration due to the rapid degradation of small peptides by the abundant proteases in the circulation of animals with acute pancreatitis; (2) measurement of TAP does not report the total trypsin-like enzymatic activity, a value required to evaluate PAR2 activation; and 3) the fluorescence-based BzArgNap assay showed the highest sensitivity among all enzymatic assays. 33 Using the procedure described in Materials and Methods, we were able to obtain reproducible and reliable results.
The tenet of our hypothesis was satisfied by measurement of trypsin activity in blood samples from the portal vein of control rats and of rats with taurocholate-induced pancreatitis. Figure 5A shows that no measurable trypsin-like activity was detected in control, sham-operated rats. By contrast, serum samples obtained from rats 6 hours after the induction of pancreatitis by taurocholate contained trypsin activity equivalent to 1.01 Ϯ 0.09 g/mL, based on the standard for trypsin activity used for all functional experiments in this study (Sigma T1426; 14,100 N␣-Benzoyl-L-arginine ethyl ester (BAEE) units per milligram of protein). To estimate the concentration of exogenous trypsin in vivo, the rats were infused with a bolus of trypsin through the jugular vein, and blood samples were collected from the portal vein 1 minute after the trypsin bolus. Exogenous trypsin infusion (2 mg/kg per 100 L) increased serum trypsin activity of control rats to 1.56 Ϯ 0.37 g/mL, a value that was not statistically different from that found in taurocholate-treated rats (P ϭ 0.37). Trypsin infusion further markedly increased serum trypsin activity in rats with taurocholate-induced pancreatitis to 4.04 Ϯ 0.71 g/mL ( Figure 5A ). Incubating serum samples with enterokinase increased trypsin activity by 140% in rats with taurocholate-induced pancreatitis (2.41 Ϯ 0.26 g/ mL), suggesting that a significant portion of trypsinogen is present in a nonactive form in the serum of rats with taurocholate-induced pancreatitis ( Figure 5B ). Hence, measurement of serum trypsin activity indicates that active trypsin concentration in the rats with taurocholate-induced pancreatitis is approximately 42 nmol/L, a concentration sufficient to activate PAR2. In fact, this is the first report to show that circulating trypsin in acute pancreatitis reaches a sufficient level to activate PAR in systemic inflammatory cells.
Protease-Activated Receptor 2 in Inflammatory Cells
To evaluate the ability of the circulating trypsin concentration to activate PAR2, we measured the effects of trypsin and PAR2-AP on several functions of cells involved in systemic inflammation. Figure 6A shows that trypsin 30 nmol/L evoked a transient increase in [Ca 2ϩ ] i in human monocyte-derived THP-1 cells. PAR2-AP 100 Figure 5 . Measurement of trypsin levels in serum of rats with taurocholate-induced acute pancreatitis. Trypsin activity was measured in blood samples collected from the portal vein of control rats and of rats with taurocholate-induced pancreatitis by using a BzArgNap-based fluorometric assay. (A) Active trypsin concentration was measured in the absence of enterokinase treatment. Induction of pancreatitis (6 hours) significantly increased serum trypsin activity, and the value was not statistically different from that measured in serum collected from rats infused with exogenous trypsin 2 mg/kg. (B) Total trypsinogen concentration was estimated after treatment of blood samples with enterokinase (10 U per reaction; 45 minutes). *P Ͻ 0.05; **P Ͻ 0.01. Activation of the transcription factor NF-B is a hallmark of the proinflammatory response of immune cells. Therefore, we measured the DNA-binding activity of nuclear NF-B by using the electrophoretic mobility shift assay. 18, 23 As shown in Figure 6C , activation of PAR2 resulted in activation of NF-B in THP-1 cells: this reached a maximum at 1 hour. Activation of NF-B leads to increased IL-8 expression in THP-1 cells. 34 IL-8 plays a critical role in the development of PALI by recruiting and activating neutrophils. 35 Therefore, we evaluated the mRNA expression of IL-8 and its release due to PAR2 activation by RT-PCR and enzyme-linked immunosorbent assay, respectively. Treatments with PAR2-AP (100 mol/L) for 1 hour caused a pronounced increase in IL-8 mRNA expression ( Figure 6D ). It is important to note that activation of PAR2-stimulated IL-8 release was maximal after 12 hours of incubation with PAR2-AP 100 mol/L.
Hypotension and increased endothelial permeability are important features of the systemic effect of acute pancreatitis. 1, 36 Therefore, it was of interest to measure the effects of PAR2 activation on endothelial cell Ca 2ϩ signaling and function. The results are shown in Figure  7 . Trypsin 30 nmol/L and PAR2-AP 100 mol/L triggered similar large transient increases in [Ca 2ϩ ] i in the HUVEC cells. Unlike the finding with THP-1 cells (Figure 6B ), exposure of HUVEC cells previously stimulated with a PAR2 agonist to trypsin 100 nmol/L resulted in a second [Ca 2ϩ ] i increase ( Figure 7B ), suggesting that the PAR2 in HUVEC is less prone to desensitization than the PAR2 in THP-1 cells. Consequently, this will result in a prolonged Ca 2ϩ signal, which is responsible for the prolonged effect of endothelial cells on smooth muscle function. Notably, activation of PAR2 in HUVEC caused stimulation of nitric oxide and possibly reactive oxygen species formation, as reported by H 2 DCF, which principally responds to peroxynitrite, the oxidized product of nitric oxide. 37 As shown in Figure 7C and D, stimulation of HUVEC cells with PAR2-AP 100 mol/L caused a rapid and sustained increase in H 2 DCF fluorescence-an effect that was largely inhibited by the nitric oxide synthase inhibitor N G -nitro-L-arginine methyl ester.
Acute Pancreatitis, Protease-Activated Receptor 2, and Systemic Blood Pressure
One of the most critical systemic effects of acute pancreatitis is hypotension. Activation of PAR2 in inflammatory ( Figure 6 ) and endothelial ( Figure 7 ) cells raised the prospect that PAR2 mediates the hypotension observed in acute pancreatitis. Therefore, we first measured the effect of trypsin infusion at concentrations found in rat serum after the induction of acute pancreatitis ( Figure 5A ) on in vivo hemodynamics. Representative traces are shown in Figure 8A , and the summary is given in Figure 8C . Notably, infusion of trypsin 2 mg/kg caused an instantaneous decrease in mean arterial pressure from 68.5 Ϯ 0.9 mm Hg to 50.5 Ϯ 2.6 mm Hg (P ϭ 0.003) in control sham-operated rats. The decrease in diastolic pressure was more prominent than the decrease in systolic pressure, with a maximum decrease of 21.8 Ϯ 1.3 mm Hg at trypsin 2 mg/kg ( Figure 8C) . Hence, the pulse pressure was increased from 22.1 Ϯ 1.3 mm Hg to 28.5 Ϯ 2.3 mm Hg (P ϭ 0.03). Another finding of note in Figure 8 is that treatments of rats with PAR2-AP 1 mg/kg reduced blood pressure similar to the reduction found with trypsin 2 mg/kg ( Figure 8D) .
The lack of a PAR2-specific antagonist led us to design alternative protocols to show a role of PAR2 in pancreatitis-induced hypotension. We reasoned that if acute pancreatitis-associated hypotension is mediated, at least in part, by PAR2 activation, then infusion of trypsin or PAR2-AP should have no or a reduced effect on the blood pressure of rats with acute pancreatitis. As expected, the induction of acute pancreatitis reduced blood pressure ( Figure 8B and C) to a mean pressure of 50.7 Ϯ 0.9 mm Hg, which is nearly identical to the blood pressure induced by the infusion of trypsin 2 mg/mL in control rats (50.5 Ϯ 2.6 mm Hg). Similarly, the induction of acute pancreatitis resulted in a pulse pressure of 29.0 Ϯ 1.3 mm Hg, which is similar to the 28.5 Ϯ 2.3 mm Hg caused by trypsin infusion in control rats. The critical findings shown in Figure 8 are that infusion of trypsin or PAR2-AP had a markedly diminished effect on the hemodynamic parameters of rats with acute pancreatitis. Thus, trypsin 2 mg/kg decreased the diastolic pressure by only 9.3 Ϯ 0.9 mm Hg in rats with pancreatitis ( Figure 8C ), whereas the same treatment caused a much greater increase in circulating trypsin activity ( Figure 5A ). Furthermore, physiologically significant hypotension was apparent by the infusion of as little trypsin as 0.2 mg/kg in control rats. This concentration of trypsin had virtually no effect on the blood pressure of rats with acute pancreatitis. Equally important was that treatment with PAR2-AP 1 mg/kg, which reduced blood pressure similarly to trypsin 2 mg/kg ( Figure 8D ), had a much reduced effect on systolic and, in particular, diastolic pressure.
In an effort to provide an additional measure for the importance of PAR2 activation in acute pancreatitis, we measured heart rate under the experimental conditions of Figure 8 . Activation of PAR2 by trypsin 2 mg/kg increased the heart rate from 358 Ϯ 11 bpm to 397 Ϯ 8 bpm (P ϭ 0.04), possibly because of a reflex sympathetic activation. This value was close to the heart rate of 411 Ϯ 18 bpm observed 6 hours after the induction of acute pancreatitis. Hence, these results are consistent with activation of PAR2 in the circulatory system during acute pancreatitis and with the hypothesis that this activation causes hypotension that may be mediated by activation of endothelial cells.
The specificity of the trypsin-induced hemodynamic changes was analyzed with the following 2 protocols. First, we tested whether the effects of trypsin could be blocked by the synthetic trypsin inhibitor camostat. A bolus infusion of camostat (20 mg/kg) to control rats induced transient hypotension and arrhythmia (not shown). However, all the hemodynamic parameters were restored to control levels within 1 minute. Trypsin was then infused 5 minutes after the camostat infusion. As shown in Figure 9A and B, pretreatment with camostat inhibited the decrease in diastolic pressure caused by trypsin 2 mg/kg by 72%. These findings indicate that the enzymatic activity of trypsin is required for trypsinmediated hypotension, which likely mediates the proteolytic cleavage of PAR2. Second, a complementary experiment was to test whether camostat could prevent the pancreatitis-induced hypotension. Camostat (20 mg/kg) was infused intravenously 4 hours after taurocholate treatment, and blood pressure was monitored for 2 hours. It is interesting to note that the camostat-infused rats showed a slow increase in blood pressure during the 2-hour observation period. When compared with salineinfused rats, the mean blood pressure of camostat-infused rats was increased by 10.6 Ϯ 2.9 mm Hg (P Ͻ 0.01; n ϭ 10). These findings are consistent with a role of trypsin and PAR2 in pancreatitis-associated hypotension.
The lack of effect of trypsin and PAR2-AP on the hemodynamic parameters of the pancreatitis rats may stem from a general loss of blood pressure regulation, loss of responsiveness to changes in [Ca 2ϩ ] i , or excessive and general organ failure. To exclude this possibility, it is necessary to show that the vasculature retains normal responsiveness to other regulators of blood pressure. This was achieved by comparing the response of control rats and those with taurocholate-induced pancreatitis to stimulation with the muscarinic agonist carbachol, a well-known hypotensive agent. Carbachol was used at 2 ng/kg because higher concentrations resulted in bradycardia. Figure 9C and D show that the hypotensive effect of carbachol was largely retained in the rats with taurocholate-induced pancreatitis. The average effect of carbachol on the diastolic pressure of the pancreatitis rats was 82% of that measured in control rats ( Figure 9D ) and was significantly higher than that of PAR2 ( Figure 8D ). These findings indicate that the decreased response to PAR2-AP in the rats with pancreatitis was not due to a general failure in vasodilation.
Discussion
Severe acute pancreatitis is a systemic disease with multiple organ failure. Although pulmonary injury is the most frequent cause of early death, other organs, such as the renal, cardiovascular, central nervous, and coagulation systems, as well as the gastrointestinal tract, are also affected. 1 Current treatment of a multiple organ dysfunction syndrome (MODS) focuses on general supportive care and prevention of organ injury. Multiple mechanisms are involved in the pathogenesis of MODS. These include several mediators of cell activity, such as kinins, ILs, and platelet-activating factor. Accordingly, inhibitors of several of these mediators were reported to have some beneficial effect in experimental pancreatitis and in early clinical trials. 1, 2, 36 However, MODS is a very complex disease, and the overall mechanisms responsible for pancreatitis-associated systemic injuries are not well un-derstood. This work provides new insight into this topic by showing that the activation of PAR2 plays multiple (beneficial and harmful) roles in severe acute pancreatitis.
The protective effect of PAR2 was quite unexpected because PAR2 is a Gq-coupled receptor that increases [Ca 2ϩ ] i . A prolonged sustained increase in [Ca 2ϩ ] i is associated with cell damage and cell death, as is the case for the effect of cholecystokinin and bile acids in pancreatic acini. 18, 25 However, in pancreatic acinar cells, PAR2 undergoes rapid desensitization with respect to Ca 2ϩ signaling (Figure 2) , which can explain the lack of toxicity. However, the PAR2 stimulated state is long lived, as is evident from the maintained phosphorylation of ERK. This can be either because of a "Ca 2ϩ memory" or because of an activation of multiple signaling pathways by PAR2. The latter is more likely because PAR2 protected pancreatic acinar cells from bile-induced damage, which is exclusively mediated by a sustained increase in [Ca 2ϩ ] i . 18 This notion is further supported by a recent report suggesting that internalization of PAR2 is required for activation of ERK in a kidney cell line. 38 PAR2 is likely to activate cell survival or suppress cell death pathways to protect the acinar cells.
It is interesting to note that PAR2 also seems to confer a protective effect on the pancreatic duct by stimulating luminal Cl Ϫ /HCO 3 Ϫ exchange and, therefore, HCO 3 Ϫ secretion. Increased ductal HCO 3 Ϫ secretion is expected to protect the pancreas in general and the pancreatic duct in particular. 39 Hence, on the basis of the findings of this study, we suggest that activation of PAR2 in the pancreas serves as an acute local defense mechanism until the cells can clear an imposed stress. Such an imposed stress is trypsin secreted across the basolateral membrane to the interstitial space during normal or pathologic situations. The abnormally secreted trypsin activates PAR2 in the basolateral membrane of acinar and duct cells to prevent cell damage. Once the PAR2 defense is overwhelmed, pancreatitis ensues. This can be by excessive trypsin secretion to cause autodigestion or by accumulation of inflammatory mediators.
The sinister part of PAR2 signaling is the activation of endothelial and immune cells that express PAR2. Once trypsin levels in the circulation reach levels sufficient to activate PAR2 in immune and endothelial cells, the systemic complications of severe acute pancreatitis are initiated or, at least, aggravated. Hyperactivation of endothelia has been suggested as central to the pathogenesis of MODS. 1, 36 Ca 2ϩ -mobilizing agonists activate endothelial cells, leading to an increased vascular permeability, activation of nitric oxide synthase, and expression of adhesion molecules. It is important to note that we found that circulating trypsin in severe acute pancreatitis reaches a level sufficient to activate HUVEC cells (Figure 7) . Furthermore, activation of Ca 2ϩ signaling by PAR2 in endothelial cells does not desensitize, leading to sustained production of nitric oxide. Of particular significance is the finding that exogenous trypsin infusion to generate a serum trypsin activity similar to that observed in experimental pancreatitis results in a hemodynamic pattern close to that observed in rats with acute pancreatitis, including hypotension, widening of pulse pressure, and reflex tachycardia. Furthermore, the effect of exogenous trypsin was not additive to that of acute pancreatitis (Figure 8 ). In addition, exogenous trypsin infusion increased the circulating trypsin in rats with taurocholate-induced pancreatitis to a higher level than that measured in control rats ( Figure 5 ). This suggests that the native serum trypsin inhibitors, which prevent aberrant activation of PAR, may have been consumed in severe pancreatitis. This will facilitate accumulation of trypsin in the circulation to promote the systemic effect of acute pancreatitis. The combined findings led us to conclude that activation of PAR2 in endothelial cells by circulating trypsin mediates, at least in part, the acute pancreatitis-associated hemodynamic changes that eventually result in the development of MODS. Future studies with specific PAR2 antagonists could be an effective measure to test the therapeutic potential of this mechanism.
Another contributing effect of PAR2 activation to the systemic complications of acute pancreatitis is activation of neutrophils and generation of IL-8. Strong evidence implicates IL-8 involvement in PALI and MODS. 1, 35, 36 A recent study reported that activation of circulating trypsinogen induces PALI, possibly because of activation of neutrophils. 4 Accordingly, we found that circulating trypsin in pancreatitis reaches levels sufficient to activate PAR2 in monocytic THP-1 cells to stimulate IL-8 production ( Figure 6 ). Despite desensitization of the PAR2 in THP-1, IL-8 production continued to increase for at least 12 hours (Figure 6B ), again raising the possibility that PAR2 activates multiple signaling pathways or memories of PAR2 signaling.
Considering the results of this study, it should be of interest to re-evaluate the use of synthetic trypsin inhibitors in acute pancreatitis. The original logic behind the use of trypsin inhibitors for the treatment of acute pancreatitis was to block tissue damage caused by autodigestion. The clinical outcome of these trials is still controversial. 40, 41 Promising results were reported in a prospective study with gabexate mesilate, a low-molecular-weight synthetic trypsin inhibitor. Treatment with gabexate mesilate seems to prevent the early complications of human acute pancreatitis, 42 although the overall mortality and long-term complications were not affected. 43 These results may be explained by the present findings, in which inhibition of PAR2 activation by gabexate mesilate may have ameliorated the early systemic complications of acute pancreatitis. Such a treatment may have had only a short-term benefit that was not sufficient to prevent the eventual pancreatic necrosis.
Activation of PAR2 may be associated with other pathologic processes of acute pancreatitis, which were not investigated in this work. For example, PAR2 activation is associated with pain and neurogenic inflammation by way of activation of the substance P and neurokinin-1 receptor pathways. 13, 44 An early onset of severe pain is one of the major symptoms of acute pancreatitis. 5 In addition, deletion of the neurokinin-1 receptor gene or of the preprotachykinin A gene, which code for substance P and neurokinin A (NKA), partially protected against the development of PALI. 45, 46 Therefore, future studies on the associations between PAR2 activation and the diverse pathologic processes of acute pancreatitis, including pain and neurogenic inflammation, may reveal new insights in understanding the pathogenesis of acute pancreatitis.
In conclusion, this work suggests that PAR2 receptors are activated in acute pancreatitis to exert dual effects. On the one hand, activation of PAR2 serves to protect acinar and duct cells from cell damage associated with pancreatitis. On the other hand, once a sufficiently high level in the circulation is reached, trypsin activates PAR2 in endothelial and immune cells to mediate part of the systemic effects on acute pancreatitis, including hemodynamic and inflammatory complications. A detailed understanding of the roles of PAR2 activation in acute pancreatitis should guide the development of specific modalities for the treatments of acute pancreatitis, particularly in the early onset of multiple organ failure.
